|
Re: Colchicine article from medscape
|
1
|
Resverlogix Corp.
|
Feb 10, 2021 09:29AM
|
|
Re: Repetitive musings on repetitive issues
|
8
|
Resverlogix Corp.
|
Feb 13, 2021 03:10PM
|
|
Re: Repetitive musings on repetitive issues
|
4
|
Resverlogix Corp.
|
Feb 16, 2021 11:06AM
|
|
Covid opportunity
|
12
|
Resverlogix Corp.
|
Mar 08, 2021 12:55PM
|
|
Wording to Media
|
8
|
Resverlogix Corp.
|
Mar 13, 2021 11:37AM
|
|
A few thoughts
|
5
|
Resverlogix Corp.
|
Mar 15, 2021 02:31PM
|
|
Re: The cardiac pre-print now published....in Cell!
|
9
|
Resverlogix Corp.
|
Mar 16, 2021 04:00PM
|
|
Re: The cardiac pre-print now published....in Cell!
|
5
|
Resverlogix Corp.
|
Mar 16, 2021 04:05PM
|
|
Re: The cardiac pre-print now published....in Cell!
|
3
|
Resverlogix Corp.
|
Mar 16, 2021 04:07PM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
9
|
Resverlogix Corp.
|
Mar 18, 2021 09:43AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
6
|
Resverlogix Corp.
|
Mar 18, 2021 09:57AM
|
|
Re: Zenith-Oncology Pipeline
|
9
|
Zenith Epigenetics
|
Mar 18, 2021 03:12PM
|
|
Re: Zenith-Oncology Pipeline
|
5
|
Zenith Epigenetics
|
Mar 19, 2021 11:23AM
|
|
Re: Zenith-Oncology Pipeline
|
8
|
Zenith Epigenetics
|
Mar 23, 2021 01:45PM
|
|
Re: Fiercemarkets article
|
8
|
Resverlogix Corp.
|
Mar 23, 2021 01:58PM
|
|
Re: We should get financials this week
|
9
|
Resverlogix Corp.
|
Mar 23, 2021 02:07PM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 23, 2021 03:27PM
|
|
Re: New pill from Pfizer....
|
9
|
Resverlogix Corp.
|
Mar 23, 2021 03:36PM
|
|
Re: New pill from Pfizer....
|
1
|
Resverlogix Corp.
|
Mar 23, 2021 03:44PM
|
|
Re: We should get financials this week
|
8
|
Resverlogix Corp.
|
Mar 23, 2021 07:38PM
|
